Introduction {#s1}
============

In recent years, decreasing readmission rates has become a priority for US hospitals.[@i2168-9709-10-4-207-b01]-[@i2168-9709-10-4-207-b04] Preventable hospital readmissions have been estimated to cost more than \$12 billion annually, leading the Centers for Medicare and Medicaid Services to incentivize hospitals to focus on decreasing 30-day readmissions in high-risk disease states, including acute myocardial infarction, heart failure, and pneumonia.[@i2168-9709-10-4-207-b01],[@i2168-9709-10-4-207-b02] In 2012, Centers for Medicare and Medicaid Services began reducing Medicare payments for hospitals with excess readmissions through the Hospital Readmissions Reduction Program, which was created to provide financial incentives to hospitals to reduce readmissions through coordinating transitions of care and improving the quality of patient care.[@i2168-9709-10-4-207-b01] The implementation of these strategies has led to increased research focusing on measuring the impact that they have on reducing readmissions.

Although several studies have researched the prevention of readmissions for various medical diagnoses, there is little that exists in regards to psychiatric readmissions and even less on the role that medication-related factors may play in the readmissions of psychiatric patients. It has been shown that medication nonadherence is a modifiable risk factor for rehospitalization risk in the severely mentally ill population with 50% becoming nonadherent in the first month following discharge.[@i2168-9709-10-4-207-b03],[@i2168-9709-10-4-207-b05] Medication-related factors, such as number and type of psychotropic medications at discharge, medication changes made within 48 hours of discharge, and the number of medications dispensed without a documented follow-up plan, has been associated with increased hospitalization risk, leading to an interest in understanding how the complexity of a medication regimen may affect patient outcomes, including readmissions.[@i2168-9709-10-4-207-b03],[@i2168-9709-10-4-207-b06] Increasing medication regimen complexity has been found to be directly associated with nonadherence, but the characterization of medication regimen complexity in psychiatric patients has not been extensively investigated.[@i2168-9709-10-4-207-b04],[@i2168-9709-10-4-207-b07]

The medication regimen complexity index (MRCI) is a validated 65-item tool for quantifying drug regimen complexity based on the quantity of medications, dosage form, dosage frequency, and additional or special instructions.[@i2168-9709-10-4-207-b02],[@i2168-9709-10-4-207-b08],[@i2168-9709-10-4-207-b09],[@i2168-9709-10-4-207-b10] Higher weights are assigned for factors such as dosage forms with less convenient administration, strict time intervals, and additional instructions such as *break/crush tablet*. The MRCI considers disease-specific prescription medications, other prescription medications, and over-the-counter (OTC) medications, and a higher MRCI score indicates higher complexity.

Defining MRCI cutoffs to categorize medication complexity may be dependent upon the studied population, based on previous MRCI studies.[@i2168-9709-10-4-207-b04],[@i2168-9709-10-4-207-b08],[@i2168-9709-10-4-207-b10]-[@i2168-9709-10-4-207-b12] Studies have been conducted in diverse populations, and there are no consistent cutoffs that define low and high complexity in the general population. For instance, 1 study[@i2168-9709-10-4-207-b08] that evaluated the MRCI in defined populations with chronic disease (geriatric depression, human immunodeficiency virus, diabetes mellitus, and hypertension) found that the MRCI values for meeting complexity thresholds for high and low MRCI scores differed between disease-specific cohorts. For example, low-complexity geriatric depression had a mean of 13 compared with low-complexity hypertension, which had a mean of 7. High-complexity geriatric depression had a mean of 41 compared with high-complexity hypertension, which had a mean of 30.[@i2168-9709-10-4-207-b08] Additionally, impact of MRCI cutoffs on readmissions were either not reported or findings were not conclusive, limiting associations related to MRCI scores and readmission risk.[@i2168-9709-10-4-207-b04],[@i2168-9709-10-4-207-b08],[@i2168-9709-10-4-207-b10]-[@i2168-9709-10-4-207-b12] To our knowledge, only 1 study[@i2168-9709-10-4-207-b04] has looked specifically at utilizing MRCI in psychiatric patients and found average MRCI scores of 17.62 and 19.36. The study focused on adults age 65 years or older with depression and, therefore, did not represent a nonelderly psychiatric population.

Our study sought to utilize the MRCI tool to characterize regimen complexity in a high-utilizer psychiatric cohort specific to a large academic medical center that serves as the second largest of 4 inpatient psychiatric facilities in the surrounding area of the study state. Our aim is to better elucidate the MRCI scores that are common in this cohort and how they are related to readmissions. Study findings may aid in informing avenues for future research and the development of targeted clinical pharmacy interventions to reduce medication complexity and with the hope to reduce the risk for readmissions.

Methods {#s2}
=======

Study Design {#s2a}
------------

This study was a single-site, retrospective study approved by the University of North Carolina\'s Institutional Review Board. Patients admitted between July 2012 and March 2014 were included if they were age 18 years or older and were identified as a high-utilizer of inpatient psychiatric services, defined as having been discharged from an adult inpatient psychiatry service with greater than or equal to 5 psychiatric readmissions or at least one 30-day psychiatric readmission in this time frame. This criteria was selected based on previous literature defining high utilization of psychiatric patients as well as the study institution\'s utilization data provided from the institution\'s quality management team.[@i2168-9709-10-4-207-b13] Patients were excluded if they were younger than 18 years of age and/or were discharged from and readmitted to facilities other than the institution\'s psychiatric services.

Patient data was collected through the electronic hospital and pharmacy databases and the electronic medical record system. Demographics, number of readmissions, and number and type of medications for each hospital discharge and readmission were collected. Dosage form, frequency of dosing, and additional usage directions for each medication on each discharge were collected from the electronic pharmacy database to determine the complexity of the medication regimen, which was computed using the 65-item validated Microsoft Access version 1.0 (Redmond, WA) medication regimen complexity electronic data capture tool by the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences. The tool used for coding is publically available online.[@i2168-9709-10-4-207-b08]

For each hospital discharge, an MRCI was computed for 3 separate medication categories (psychotropic medications, other prescription medications, OTC medications) based on the discharge medication list. Any medication that had been prescribed for a psychiatric indication or side effect, regardless of Food and Drug Administration-approved indication (eg, propranolol for akathisia), was categorized as a psychotropic medication. The 3 scores were then combined to calculate the total MRCI score for that discharge. An average total MRCI score was computed for each patient by averaging the total MRCI scores from each discharge, and an average MRCI score for each of the 3 medication categories was also computed by averaging the MRCI scores for each medication category from each discharge.

The medication count for each of the 3 medication categories at first discharge and the total medication count at first discharge were recorded. The average total medication count for each patient and the average medication count for each medication category were also computed and recorded. To determine the time to readmission, the number of days between first hospital discharge and first hospital readmission was calculated for each patient, and the average time to readmission for each patient was determined by averaging the number of days between each hospital discharge and readmission. The number of hospital readmissions was totaled for each patient to determine the patient\'s readmission frequency.

Data Analysis {#s2b}
-------------

Data was recorded without patient identifiers, and confidentiality was maintained. Descriptive statistics were utilized to analyze baseline characteristics. Student *t* test and ANOVA were used for comparing means, and Pearson\'s correlation was utilized to calculate correlations using statistical software Stata, version 16.0 (College Station, TX).

Results {#s3}
=======

A total of 174 patients were identified, and 168 patients were included in data analysis. Six patients were excluded due to not fully meeting inclusion criteria. [Table 1](#i2168-9709-10-4-207-t01){ref-type="table"} provides demographic information. The mean age was 41.3 years (range 18 to 94), and the majority were female (56%) and unemployed (51%). All patients had only 1 primary diagnosis recorded, and the average number of comorbid psychiatric diagnoses per person was 0.69 (range 0 to 3). Length of stay ranged from 2 to 84 days, and time between readmissions ranged from 1 to 504 days. Total number of readmissions ranged from 2 to 9. Ninety percent had psychiatric readmissions within 30 days. Eight percent had both 5 or more psychiatric admissions and readmissions within 30 days, and 2% had 5 or more psychiatric admissions only.

###### 

Baseline characteristics of patient population

  Patient Characteristic                                                    No. (%)
  ------------------------------------------------------------------------- ----------
  Sex                                                                       
   Male                                                                     74 (44)
   Female                                                                   94 (56)
  Race                                                                      
   White                                                                    109 (65)
   African American                                                         42 (25)
   Asian                                                                    4 (2)
   Other                                                                    13 (8)
  Age, y                                                                    
   \<25                                                                     30 (18)
   25-44                                                                    71 (42)
   45-64                                                                    57 (34)
   \>65                                                                     10 (6)
  Employment                                                                
   Employed                                                                 25 (15)
   Unemployed                                                               86 (51)
   Unknown                                                                  55 (33)
  Insurance                                                                 
   Medicaid/Medicare                                                        17 (11)
   Private                                                                  14 (9)
   Unknown                                                                  132 (80)
  Primary and comorbid diagnoses                                            
   Bipolar                                                                  31 (19)
   Depressive disorder                                                      52 (31)
   Unspecified depressive disorder or unspecified bipolar disorder          29 (17)
   Schizophrenia                                                            23 (14)
   Schizoaffective disorders                                                24 (14)
   Substance-related disorders                                              25 (15)
   Other                                                                    55 (33)
  High-utilizer criteria                                                    
   Psychiatric readmission within 30 d                                      152 (90)
   ≥5 Psychiatric readmissions only                                         3 (2)
   ≥5 Psychiatric readmissions *and* psychiatric readmissions within 30 d   13 (8)
  Length of stay, d                                                         
   0-4                                                                      125 (25)
   5-9                                                                      206 (41)
   10-14                                                                    79 (16)
   15-19                                                                    29 (6)
   20 or more                                                               57 (11)
  Time between readmissions, d                                              
   0-5                                                                      68 (20)
   6-10                                                                     50 (15)
   11-15                                                                    41 (12)
   16-20                                                                    23 (7)
   21-25                                                                    29 (9)
   26-30                                                                    9 (3)
   31-60                                                                    29 (9)
   61-90                                                                    26 (8)
   91-120                                                                   17 (5)
   \>120                                                                    45 (13)
  No. of psychiatric readmissions                                           
   2                                                                        86 (51)
   3                                                                        45 (27)
   4                                                                        21 (13)
   5                                                                        12 (7)
   6                                                                        5 (3)
   7                                                                        1 (1)
   8                                                                        0 (0)
   9                                                                        1 (1)

MRCI Score and Readmission Risk by Demographics {#s3a}
-----------------------------------------------

There were some demographics with significant differences in MRCI ([Table 2](#i2168-9709-10-4-207-t02){ref-type="table"}). Specifically, age 65 years or older and female sex were associated with a higher average MRCI (*P* = .0001, *P* = .0032, respectively). A diagnosis of schizophrenia was found to be associated with a lower average MRCI (*P* = .046). When evaluating readmissions, those with major depressive disorder had a shorter time to readmission (18 days) compared to other diagnoses (31 to 67 days; *P* = .0185). No demographic variables were associated with readmission frequency.

###### 

Medication regimen complexity index (MRCI) and associations to readmission by demographic data

  **Patient Characteristic**            **MRCI Average**   **Time to Readmission, d**   **Readmission Frequency, N**
  ------------------------------------ ------------------- ---------------------------- ------------------------------
  Age, y                                                                                
   \<25                                       12.59        28.28                        2.79
   25-44                                      13.61        41.56                        3.00
   45-64                                      20.01        34.07                        2.93
   \>65                                       23.75        22.22                        2.78
   *P* value                                  .0001        NS                           NS
  Sex                                                                                   
   Female                                     17.81        35.77                        2.94
   Male                                       13.88        35.97                        2.92
   *P* value                                  .0032        NS                           NS
  Race                                                                                  
   White                                      16.98        33.67                        2.97
   African American                           15.26        52.02                        3.05
   Asian                                      8.98         27.25                        2.50
   Other                                      13.26        6.44                         2.44
   *P* value                                   NS          NS                           NS
  Length of stay, d                                                                     
   0-4                                        13.34        39.43                        2.84
   5-9                                        17.91        34.68                        3.01
   10-14                                      18.81        28.66                        3.03
   15-19                                      10.96        8.75                         2.38
   20 or more                                 16.31        55.83                        2.66
   *P* value                                   NS          NS                           NS
  Employment                                                                            
   Employed                                   15.55        26.08                        2.92
   Unemployed                                 14.07        29.26                        2.91
   Unknown                                    19.36        50.92                        2.96
   *P* value                                   NS          NS                           NS
  Insurance                                                                             
   Medicare/Medicaid                          16.95        28.88                        3.12
   Private                                    14.12        46.43                        3.07
   Uninsured                                  15.26        35.95                        2.87
   *P* value                                   NS          NS                           NS
  Diagnosis                                                                             
   Bipolar disorder                           20.11        48.58                        3
   Depressive disorder                        14.92        18.78                        2.76
   Unspecified depressive or bipolar          16.22        67.24                        3.21
   Schizophrenia                              12.75        31.13                        2.95
   Schizoaffective disorders                  13.88        44.41                        3.29
   Substance-related disorders                13.90        52.11                        3.11
   Other                                      13.26        ...                          ...
   *P* value                                  .046         .0185                        NS
  Percentiles (range)                                                                   
   25                                     6.21 (0-8.8)     59.51                        3.16
   50                                   11.81 (8.9-14.3)   33.15                        3.02
   75                                   16.73 (14.4-19.7)  33.21                        3.00
   99                                   20.06 (19.8-55.2)  14.62                        2.45
   *P* value                                  .001         .026                         NS

NS = not significant.

MRCI Score: Psychotropic Medications {#s3b}
------------------------------------

The MRCI scores for psychotropic medications are in [Table 3](#i2168-9709-10-4-207-t03){ref-type="table"}. At first hospital discharge, the MRCI for psychotropic medications was unrelated to the days between first discharge and first readmission. However, the average MRCI for psychotropic medications for all readmissions was 7.09 and was significantly associated with time between each readmission (*P* = .044). There was no significant association between the average MRCI for psychotropic medications and readmission frequency ([Table 3](#i2168-9709-10-4-207-t03){ref-type="table"}).

###### 

Correlation data for medication regimen complexity index (MRCI)^a^

  **Variable**                      **MRCI (range)**   **Days Between First Discharge and First Readmission**   **Average Days Between Each Readmission**   **Readmission Frequency**
  --------------------------------- ------------------ -------------------------------------------------------- ------------------------------------------- --------------------------------------
  MRCI at first discharge                                                                                                                                   
   Psychotropic                     6.86 (0-19)        *r* = .065 *P* = .40                                     ...                                         ...
   Other prescription               6.01 (0-46)        *r* = --.00028 *P* = 1.00                                ...                                         ...
   Over the counter                 2.53 (0-19.5)      *r* = --.047 *P* = .54                                   ...                                         ...
   Total                            15.36 (0-62.5)     *r* = .0054 *P* = .94                                    ...                                         ...
  Average MRCI (all readmissions)                                                                                                                           
   Psychotropic                     7.09 (0-17.5)      ...                                                      ***r*** **= .16** ***P*** **= .044**        *r* = .11 *P* = .16
   Other prescription               5.90 (0-38.25)     ...                                                      *r* = --.03 *P* = .70                       *r* = .049 *P* = .53
   Over the counter                 2.98 (0-18.9)                                                               *r* = .059 *P* = .44                        ***r*** **= .17** ***P*** **= .029**
   Total                            16.00 (0-57.75)                                                             *r* = .064 *P* = .41                        *r* = .14 *P* = .07

Boldface indicates statistical significance *P* \< .05.

MRCI Score: Other Prescription Medications {#s3c}
------------------------------------------

The MRCI scores for other prescription medications are in [Table 3](#i2168-9709-10-4-207-t03){ref-type="table"}. For this category, no significant associations were found between the MRCI at first hospital discharge and time to first readmission. Similarly, the average MRCI for other prescription medications was unrelated to time to each readmission or readmission frequency.

MRCI Score: OTC Medications {#s3d}
---------------------------

The MRCI scores for OTC medications are in [Table 3](#i2168-9709-10-4-207-t03){ref-type="table"}. No significant association was found between the MRCI at first hospital discharge for OTC medications and time to first readmission. However, a significant association was found between the average MRCI for OTC medications and readmission frequency (*P* = .029) but no significant association with the time between each readmission.

MRCI Score: Total {#s3e}
-----------------

The total MRCI scores are in [Table 3](#i2168-9709-10-4-207-t03){ref-type="table"}. For this category, no significant associations were found between the total MRCI at first hospital discharge and time to first readmission. Similarly, the average total MRCI was unrelated to time to each readmission or readmission frequency. However, a significant association was found when the average total MRCI scores were split into percentiles. The mean MRCI ranged from 6.21 for the 25th percentile to 20.06 for the 99th percentile. An MRCI in the highest (99th) percentile (range 19.8 to 55.2) was associated with shorter times to readmission compared to the 25th, 50th, and 75th percentiles (14 days vs 59, 33, and 33 days, respectively, *P* = .026).

Medication Count {#s3f}
----------------

The medication counts for all MRCI categories are in [Table 4](#i2168-9709-10-4-207-t04){ref-type="table"}. The average total medication count at first discharge was 5.76, and the average medication count for all readmissions was 5.83. Of all the MRCI medication categories, there was a significant association between the average psychotropic medication count (2.66) for all readmissions and the average time to readmission (*r* = .18, *P* = .019). The top 3 psychotropic medication classes prescribed at discharge were sedative hypnotics (n = 80, 25%), antipsychotics (n = 324, 24%), and antidepressants (n = 283, 22%). No other significant associations to readmission were found for medication counts for other categories.

###### 

Correlation data for medication count^a^

  **Variable**                                  **Average Medication Count (range)**   **Days Between First Discharge and First Readmission**   **Average Days Between Each Readmission**   **Readmission Frequency**
  --------------------------------------------- -------------------------------------- -------------------------------------------------------- ------------------------------------------- ---------------------------
  Medication count at first discharge                                                                                                                                                       
   Psychotropic                                 2.63 (0-8)                             *r* = .096 *P* = .22                                     ...                                         ...
   Other prescription                           2.14 (0-15)                            *r* = --.0092 *P* = .91                                  ...                                         ...
   Over the counter                             0.99 (0-8)                             *r* = --.041 *P* = .60                                   ...                                         ...
   Total                                        5.76 (0-22)                            *r* = .063 *P* = .42                                     ...                                         ...
  Average medication count (all readmissions)                                                                                                                                               
   Psychotropic                                 2.66 (0-6)                             ...                                                      ***r*** **= .18** ***P*** **= .019**        *r* = .11 *P* = .17
   Other prescription                           2.07 (0-12.67)                         ...                                                      *r* = --.04 *P* = .61                       *r* = .05 *P* = .52
   Over the counter                             1.09 (0-6.67)                          ...                                                      *r* = .036 *P* = .64                        *r* = .14 *P* = .063
   Total                                        5.83 (0-18)                            ...                                                      *r* = .052 *P* = .50                        *r* = .13 *P* = .091

Boldface indicates statistical significance *P* \< .05.

Discussion {#s4}
==========

To our knowledge, this is the first study to assess MRCI scores and their association to readmissions in a sample of adult, high-utilizer psychiatric patients. A previous study[@i2168-9709-10-4-207-b13] in psychiatric patients defined high utilizers based on service utilization, such as 6 visits in 1 year or 4 visits within 1 quarter. To date, there are limited studies that have investigated the MRCI in psychiatric patient populations outside of those greater than 65 years of age and with depression.[@i2168-9709-10-4-207-b04] The findings of our study can inform future research on this topic in psychiatric adult patients age 18 years or older with a variety of psychiatric diagnoses and frequent psychiatric readmissions.

In comparison to the 1 published study[@i2168-9709-10-4-207-b04] in psychiatry patients that reported average MRCI scores of 17.62 and 19.36 for geriatric patients, our study found a lower total average MRCI score of 16.00. This could be explained by our patient sample not being limited to geriatric patients, who tend to have a higher number of chronic medications. To our knowledge, this is the first study to report on MRCI percentiles and impact on readmission in psychiatric patients, indicating MRCI scores greater than 19.7 may result in a shorter time to readmission. Additional studies should be conducted in psychiatric patients to expand on our findings to better define high- or low-complexity scores and relation to readmissions for this unique population.

Other findings also suggest that patient characteristics, specifically age and sex, significantly impact MRCI and readmissions and that specific MRCI categories impact readmissions. Although one may suspect that the complexity of a patient\'s entire medication regimen and the total medication count would contribute to a shorter time to readmission, this study found that it was only the complexity of the psychotropic medication regimen and psychotropic medication count that impacted the time to readmission, specifically in those who had more than 1 readmission. Therefore, findings suggest that, in addition to MRCI scores greater than 19.7, using average psychotropic medication count, average psychotropic MRCI, and depression diagnosis in the risk stratification for readmissions may be warranted. Although these findings should not undervalue the importance of reviewing the entire medication regimen as a whole, for psychiatric patients with frequent readmissions, a more targeted focus on these factors at discharge may have more influence on time to subsequent readmission. Last, ensuring a thorough medication review on OTC medications as an additional factor is important in the holistic care of patients, considering OTC regimen complexity was associated with higher readmission frequency.

It should be noted that there may be barriers to implementing the MRCI tool in practice. In this study, the MRCI score for each patient was hand-coded by 1 investigator using the Microsoft Access database. This process can be time-consuming and prone to human error. Automated coding in a patient\'s electronic medical record is more clinically relevant and practical in the inpatient practice setting as incorporating an automated algorithm into the electronic medical record reduces individual coding error and would allow for quick and efficient identification of high-risk patients.[@i2168-9709-10-4-207-b04],[@i2168-9709-10-4-207-b13]-[@i2168-9709-10-4-207-b15] By implementing a tool such as the MRCI in the electronic medical record, members of the care team may be able to use it as an additional factor to more easily identify patients who would benefit from increased attention and targeted services throughout transitions of care. It is important to note, additional services can address complex medication regimens and also improve overall transitions of care and include obtaining medication histories, performing medication reconciliation, discharge medication reconciliation review and medication education, postdischarge calls, and hospital follow-up visits. The impact of these interventions, including proposed benefits of MRCI implementation, warrants further study.

There are several limitations to this study. First, the MRCI tool was created on the basis that multiple and unique dosage formulations, dosing frequencies, and additional instructions likely complicate a patient\'s ability to maintain appropriate and consistent medication administration practices. However, for psychiatric patients, the demands of maintaining medication adherence may be further complicated by other factors, such as unstable mental capacity and social stigma surrounding psychiatric diagnoses.[@i2168-9709-10-4-207-b03] Future studies should evaluate the impact of multiple factors on adherence. Additionally, the definition of a high-utilizer cohort for this study may have skewed the interpretation of the results. Although only a small percentage had 5 or more admissions, 78% of the patients did have 2 to 3 psychiatric admissions. Results may not be generalizable to broader psychiatric populations based on the nonrandomized patient sample from a single institution.

Despite the limitations noted, the study findings provide insight into patient-specific and medication complexity factors of psychiatric patients who utilize services frequently and highlight factors that are most associated with lengthening time to subsequent readmissions. This study reflects a preliminary step in the investigation of this topic, necessitating future studies in a broader psychiatric population to expand on these findings and gain a more comprehensive understanding of the significance of MRCI. Assessing the relationship of severity of illness and medication complexity on adherence and readmissions should also be explored. In addition, evaluation of the use of an automated MRCI tool to help identify patients for targeted transitions of care services to decrease medication complexity in high utilizers could be helpful.

Conclusion {#s5}
==========

In a sample of psychiatric patients with a history of frequent readmissions, age and sex were associated with higher MRCI scores. Psychotropic regimen complexity, psychotropic medication count, total MRCI greater than 19.7, and having depression contributed to a shorter time to readmission. More research is needed to confirm our findings and determine the clinical significance of the MRCI score and the impact of targeted services on MRCI at discharge.
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